TCL Archive Final Count On Funded CCOPs Probably Delayed for Months; Many To Continue Without NCI Money April 24, 1987
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
